Upon neuregulin stimulation, both ErbB3 and ErbB3 phosphorylation sites on PROTAC are phosphorylated, leading to recruitment, ubiquitinylation, and subsequent degradation of PI3K, and thereby reduced tumor growth by 40% in a murine model with no apparent side effects [20]. The gene discussed is ERBB3; the disease is neoplasm.